RxData news in Switzerland
Company News | Feb. 9, 2015
As RxData is expanding its footprint in the major pharma market in Europe, Lawrence Monoson makes the front page of l’AGEFI, a top Swiss financial newspaper, with an estimated 15,000 daily readers. RxData is described as one of the most innovative startup companies for 2015, and more importantly as one resolving an unmet need: the lack of readily available market access data, essential to any due diligence, R&D or commercialization strategies for pharmaceutical companies.
Press Releases
- [ISPOR 2023 - Impacting Innovation, Value and Healthcare Decision Making
May 7, 2023](/content/blog/ispor-2023-impacting-innovation-value-and-healthcare-decision-making/index.html) - [RxData and Edra enter into a long-term partnership
July 19, 2022](/content/blog/rxdata-and-edra-enter-long-term-partnership/index.html) - [RxData leverages First Databank content for its U.S. drug pricing component
Oct. 3, 2016](/content/blog/rxdata-leverages-first-databank-content-its-us-drug-pricing-component/index.html) - [Seed Round of Capital
March 15, 2015](/content/blog/seed-round-capital/index.html) - [RxData news in Switzerland
Feb. 9, 2015](/content/blog/rxdata-news-switzerland/index.html) - [RxData joins Blueprint Health accelerator
July 18, 2014](/content/blog/rxdata-joins-blueprint-health-accelerator/index.html)